Literature DB >> 6662139

Acycloguanosine therapy of the localized form of herpes simplex virus infection in a low-birth-weight infant.

M Futamura, H Nagae, K Ishikawa, M Ouchi, M Kuroyanagi, T Morishima.   

Abstract

It is known that the localized form of herpes simplex virus (HSV) infection does not always show a good prognosis. A preterm infant who evidenced skin and tongue lesions, caused by HSV type 1, was treated by acycloguanosine. The result was satisfactory without any complications. Therefore, a localized form of HSV infection of the newborn infant, even though the patient has a low-birth-weight, should be treated by the drug immediately after the observation of the positive HSV culture.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662139     DOI: 10.1007/bf00496801

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  TRANSPLACENTAL INFECTION BY HERPES SIMPLEX VIRUS.

Authors:  J E MITCHELL; F C MCCALL
Journal:  Am J Dis Child       Date:  1963-08

2.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 3.  Infection of the newborn with herpesvirus hominis.

Authors:  A J Nahmias; C A Alford; S B Korones
Journal:  Adv Pediatr       Date:  1970

4.  Congenital herpes simplex virus infection initially resembling epidermolysis bullosa.

Authors:  P J Honig; D Brown
Journal:  J Pediatr       Date:  1982-12       Impact factor: 4.406

5.  The natural history of herpes simplex virus infection of mother and newborn.

Authors:  R J Whitley; A J Nahmias; A M Visintine; C L Fleming; C A Alford
Journal:  Pediatrics       Date:  1980-10       Impact factor: 7.124

6.  Use of acyclovir in premature and term neonates.

Authors:  A S Yeager
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.